Reference Dose Levels During Fluoroscopically Guided Procedures in Operating Rooms

NCT03649451 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8840

Last updated 2020-05-13

No results posted yet for this study

Summary

This study is conducted by a working group of the French Society of Medical Physics (SFPM). Its main aim is to establish reference dose levels for the most common procedures performed in operating rooms using mobile X-ray systems, hence helping medical physicists and surgeons to evaluate their practice and optimize patient radiation protection.

This is a multi-centric prospective study involving 73 medical institutions of different categories (public university hospitals, clinics, centers dedicated to cancer treatment, etc.). It consists on progressively collecting anonymous data for 15 to 30 procedures from a list of 62 types of procedures, belonging to 7 surgery specialties (neurosurgery, orthopedic surgery, digestive surgery, urology, cardiology, vascular surgery and multi-specialty). Collected data include patient BMI and information about the X-ray equipment, the medical procedure and the dosimetric parameters. Data collection doesn't require the access to the patient medical record and doesn't impact his medical care.

Proposed dose reference levels will be expressed in terms of KAP (Kerma-Area-Product), fluoroscopy time and air Kerma. Moreover, multiple statistical analyses will be done to investigate the impact of different variables on the procedure X-ray doses.

Conditions

  • Radiation Exposure

Sponsors & Collaborators

  • Hopital Lariboisière

    collaborator OTHER
  • University hospital, Angers, FRANCE

    collaborator UNKNOWN
  • University hospital of Montpellier, FRANCE

    collaborator UNKNOWN
  • Fréjus-Saint-Raphaël hospital, FRANCE

    collaborator UNKNOWN
  • C2i Santé, FRANCE

    collaborator UNKNOWN
  • Societe Francaise de Physique Medicale

    lead OTHER

Principal Investigators

  • Djamel DABLI, PhD · University hospital of Nîmes, France

  • Brice ROYER, MS · C2i Santé, FRANCE

  • Mathilde DEMONCHY, PhD · Fréjus-Saint-Raphaël hospital, FRANCE

  • Julien LE ROY, PhD · University hospital of Montpellier, FRANCE

Eligibility

Min Age
16 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-03
Primary Completion
2019-03-30
Completion
2019-08-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03649451 on ClinicalTrials.gov